Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.
The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the global trade war.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback